Overview

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

Status:
Withdrawn
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is being done to assess the pharmacokinetics of SCH 900800 in participants with moderate to severe Parkinson's Disease (PD) being treated with L-DOPA.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.